Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | BDKRB2 | P30411 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3627704 | 1.00 | DNM1 (0.59) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL3326492 | 0.97 | DNM1 (0.55) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL3627860 | 0.95 | DNM1 (0.59) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL3629835 | 0.95 | DNM1 (0.59) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL18604248 | 0.95 | DNM1 (0.59) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL307489 | 0.95 | DNM1 (0.59) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL3627501 | 0.95 | DNM1 (0.59) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL3327816 | 0.92 | DNM1 (0.55) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL4532139 | 0.90 | DNM1 (0.74) | DNM1TSHRTHRBBDKRB2LMNA | |
| SCHEMBL344163 | 0.90 | DNM1 (0.74) | DNM1TSHRTHRBBDKRB2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357822-B2 | Process for producing high-purity chlorophosphite | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2013-01-22 | — | — | US | disclosed |
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | PHOSPHO1, RPP30, PCBP1 | DNM1 3817/4885TSHR 2492/4885THRB 3078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.